S ystemic lupus erythematosus (SLE) induces multiple organ damage associated with the overproduction of various autoantibodies and inflammatory cell infiltration (1) . Decreased IL-2 production is a well-known characteristic of both human and murine SLE (2, 3) . Reduced IL-2 production is related to the impairment of regulatory T cells (Tregs) in SLE patients and in a murine model of SLE (4, 5) , suggesting that the dysregulation of IL-2 contributes to the autoimmune phenomena in SLE.
The mechanisms involved in the IL-2 defect in SLE have been elucidated in part by the discovery of various transcription factors that bind to the IL-2 promoter. In SLE, phosphorylated cAMP response element modulator, an IL-2 suppressor, is aberrantly upregulated compared with the IL-2 activator phosphorylated CREB, in contrast to healthy controls under stimulation (6, 7) . This imbalance is further exacerbated by increased levels of calcium calmodulin kinase IV (8) and serine/threonine protein phosphatase 2A (9) .
Zinc finger E-box binding homeobox (ZEB)1 and ZEB2 are transcription factors belonging to the ZEB family and close homologs characterized by two clusters of zinc fingers separated by a homeodomain (10) . ZEB1 and ZEB2 bind to various promoters by their zinc finger motif and play a vital role in the development of the vertebrate embryo; these proteins are crucial for the maturation of the neural duct and cranial organs (10) . Recently, ZEB1 and ZEB2 have been recognized as important players in the induction of the epithelial-mesenchymal transition (EMT), which shift the phenotype of tumor cells to induce invasion into the surrounding tissues and metastasis (11) (12) (13) . Besides, ZEB1 targets and suppresses IL-2 by recruiting a corepressor, C-terminal binding protein 2 (CtBP2) (14) (15) (16) (17) . ZEB1 was identified as a negative regulator of IL-2 (Nil-2-a) that binds to a negative regulatory element (NRE)-A in the IL-2 promoter (14) . ZEB1 and ZEB2 need CtBP2 that directly binds to the Pro-Leu-Asp-Leu-Ser (PLDLS) sequence in ZEB1 and ZEB2 and is essential for them to exert their suppressive activity (18) . However, despite the powerful IL-2 suppression ability of ZEB1, ZEB2, and CtBP2, the function of the ZEB family and CtBP2 in autoimmune diseases is unknown.
MicroRNAs (miRNAs) are small noncoding RNAs that bind to the 39 untranslated region (UTR) of target genes and degrade mRNA or arrest translation (19) . Recent studies have shown growing evidence that various miRNAs control SLE pathogenesis (20) . However, only two reports have been published on miRNAs that regulate IL-2 in SLE. The downregulation of miRNA (miR)-31 in peripheral blood T cells has been reported in patients with SLE, which reduces IL-2 by decreasing RhoA (21) . It was also reported that the underexpression of miR-155 in juvenile SLE PBMCs is related to a lower production of IL-2 via the increased expression of the catalytic subunit of serine/threonine protein phosphatase 2A (22) .
In the present study, we found that miR-200a-3p, an miR-200 family miRNA that was previously reported as a regulator of cancer metastasis by directly suppressing promoter activity of ZEB1 and ZEB2 genes, was significantly downregulated in the MRL/lpr-Tnfrsf6 lpr (MRL/lpr) lupus-prone mouse compared with control mouse. We demonstrated that miR-200a-3p plays a critical role in the regulation of the IL-2 expression through ZEB1, ZEB2, and CtBP2 in EL4 T cells. Furthermore, we showed that the ZEB1-CtBP2 complex failed to dissociate from the IL-2 gene after PMA/ionomycin (Iono) stimulation in mouse primary CD4 + T cells, which explains the mechanism of the IL-2 defect in SLE. Our study presents novel data in the epigenetic control of IL-2 production in systemic autoimmunity.
Materials and Methods

Mice
Genetic lupus-prone female MRL/lpr and their control C57BL/6J (B6) mice were purchased from The Jackson Laboratory and Charles River Laboratories, respectively. The sample of female MRL/MpJ at 16 wk old was procured and studied at the Beth Israel Deaconess laboratories (Institutional Animal Care and Use Committee approval 088-2015). At 8 and 14-16 wk of age, MRL mice and B6 mice were sacrificed, and their spleen tissues were collected. The experiments were approved by the Animal Care and Use Committee of the Department of Animal Resources, Advanced Science Research Center, Okayama University (OKU-2015569 and OKU-2013092).
Isolation of mouse primary T cells
Mouse primary CD4 + T cells were isolated using a CD4 isolation kit II (Miltenyi Biotec) by negative selection. A purity rate of .96.6% for isolated CD4 + T cells was confirmed by flow cytometry.
miRNA profiling using a next-generation sequencer Total RNA, including miRNA, was purified from CD4 + T cells of MRL lupus-prone mice and B6 control mice using an miRNeasy mini kit (Qiagen). The quality of the total RNA was confirmed by spectrophotometry using an Agilent 2100 Bioanalyzer (Agilent Technologies). Small RNAs were then subjected to the Illumina TruSeq small RNA sample preparation protocol (Illumina). mRNAs were subjected to the Illumina TruSeq RNA sample preparation protocol. Sequencing was performed using Illumina HiSeq. In each group, the read numbers of miRNA/mRNA were counted, after which the miRNA/mRNA list was drafted by comparing the downregulated miRNA with the concomitantly upregulated mRNA and comparing the upregulated miRNA with the concomitantly downregulated mRNA. All raw and processed data are freely accessible in the Gene Expression Omnibus (https://www.ncbi.nlm.nih.gov/geo/) under the accession number GSE87219.
Cells, cell culture, and stimulation
The EL4 mouse T cell line was obtained from the American Type Culture Collection and cultured in DMEM (Life Technologies) supplemented with 10% FBS (Life Technologies), 100 U/ml penicillin, and 100 mg/ml streptomycin. A total of 10 6 cells/ml (EL4 cells or MRL-and B6-derived CD4 + T cells) were stimulated with PMA (10 ng/ml; Sigma-Aldrich) and Iono (1 mM; SigmaAldrich) at 37˚C in a 5% CO 2 incubator. For anti-CD3/CD28 stimulation, EL4
T cells were stimulated with plate-bound anti-CD3 Abs (2 mg/ml; BioLegend) and anti-CD28 Abs (2 mg/ml; BioLegend). Cells were stimulated with PMA/ Iono for 6 h or stimulated with anti-CD3/CD28 Abs for 24 h.
RNA isolation and real-time RT-PCR
Total cellular RNAs were extracted with an miRNeasy mini kit (Qiagen). cDNAs were reverse transcribed from mRNAs with a high-capacity cDNA RT kit (Thermo Fisher Scientific) and cDNAs from miRNAs with a TaqMan miRNA reverse transcription kit (Thermo Fisher Scientific). Real-time PCRs for miR-200a-3p (000502), miR-181a-5p (000480), miR-101a-3p (002253), miR-466p-3p (464896_mat), sno-202 (001232), and sno-234 (001234) were performed using TaqMan primer/probes with TaqMan miRNA assays (Thermo Fisher Scientific) and normalized to sno-202 and/or sno-234 by the DDCt method. Real-time PCRs for IL-2 (Mm00434256_m1), ZEB1 (Mm00495564_m1), ZEB2 (Mm00497193_m1), CtBP2 (Mm00515572_m1), and GAPDH (Mm99999915_g1) were performed using ABI TaqMan gene expression assays (Applied Biosystems) and normalized to GAPDH by the DDCt method.
Transfection of miRNA mimics
The transfection of miRNA mimics (mirVana; Invitrogen) was performed with Lipofectamine RNAiMAX (Invitrogen) by the reverse transfection procedure. Cells were transfected with miR-200a-3p mimic or its negative control at a final concentration of 10 nM and harvested 24 h later.
Transfection of plasmid and luciferase assay EL4 cells were cotransfected with 0.5 ng of pRL-TK Renilla plasmid (Promega) and 100 ng of IL-2 promoter firefly reporter plasmids [pIL-2 (-585)-Luc] (a gift from Dr. A. Rao, Addgene plasmid no. 12194) using Neon electroporation system (Thermo Fisher Scientific) in serum-free medium with one pulse with a voltage of 1080 V and width of 50 ms. Twenty-four hours after transfection, 10 6 cells/ml were stimulated with 10 ng/ml PMA and 1 mM Iono. Twenty-four hours after stimulation, the cells were lysed and assayed for luciferase activity using a Dual-Luciferase reporter assay system (Promega) in accordance with the manufacturer's instructions. Cotransfection of a Renilla luciferase plasmid (pRL-TK) was performed to normalize the assays.
ELISA
The amount of IL-2 protein secreted in the supernatants from cell cultures was measured by ELISA in accordance with the manufacturers' instructions (mouse IL-2 ELISA Ready-SET-Go!; eBioscience). The absorbance was determined using a microplate reader set at 450 nm.
EMSA
Nuclear extracts were prepared from EL4 cells using NXTRACT (SigmaAldrich). For binding assays (20 ml final volume), 80 mg of total nuclear extract from EL4 cells was incubated with 1 mg of 39 biotin-labeled oligonucleotide in the presence of 2 ml of 103 binding buffer (100 mM Tris, 500 mM KCl, 10 mM DTT [pH 7.5]), 1 ml of 50% glycerol, 1 mg/ml poly(deoxyinosinic-deoxycytidylic) acid,1% Nonidet P-40, and 10 mM ZnSO 4 at room temperature for 20 min. The oligonucleotides used in the binding and competition assays were as follows: murine NRE-A sequence, 59-CTGCCACACAGGTAAAGTCTT-39; mutant NRE-A sequence, 59-CTGCCACACATTTAAAGTCTT-39 (mutation underlined). Both 39 biotinlabeled and unlabeled dsNRE-A and dsNRE-A mutant oligonucleotides (Sigma-Aldrich) were prepared by annealing the single stranded complementary oligonucleotides. All competitors were used at 200-fold excess. For supershift experiments, the nuclear extracts were incubated with anti-ZEB1 Ab (1:100) (TCF8/ZEB1 no. 3396; Cell Signaling Technology), anti-ZEB2 Ab (1:25) (anti-Smad interacting protein no. 138222; Abcam), and antiCtBP2 Ab (1:25) (no. 13256; Cell Signaling Technology). The binding mixtures were loaded onto a 6% native acrylamide gel (Thermo Fisher Scientific) in Tris/borate/EDTA buffer and electrophoresed for 50 min at room temperature under a constant 100 V. The gels were then transferred to a nylon membrane at 4˚C for 50 min under a constant 100 V and exposed to UV light to crosslink for 15 min. The DNA binding activity was detected using a LightShift chemiluminescent EMSA kit (Thermo Fisher Scientific). The image was obtained using an LAS-3000 IR.
Chromatin immunoprecipitation assay
Chromatin immunoprecipitation (ChIP) analysis was performed in accordance with the manufacturer's instructions (no. 9005S; Cell Signaling Technology). Briefly, cells were cross-linked with 1% formaldehyde. After the cross-linked cells were lysed, the chromatin was harvested and frag-mented with enzymatic digestion using micrococcal nuclease. Nuclear extracts were further treated with an ultrasound sonicator with six sets of 20-s pulses. Immunoprecipitations were performed with ZEB1 (TCF8/ ZEB1 no. 3396; Cell Signaling Technology), ZEB2 (anti-Smad interacting protein no. 138222; Abcam), and CtBP2 (no. 13256; Cell Signaling Technology) Abs. After DNA-protein cross-links were reversed, the DNA was purified, and quantitative real-time PCR was performed with the primer pairs as follows: (forward) 59-TCCAGAGAGTCATCAGAAGAGG-39 and (reverse) 59-TGGGGGTGTCACGATGTTTTAC-39.
Statistical analyses
All results are shown as the mean 6 SEM of data from at least three separate experiments, each performed with more than triplicate samples. The differences between the groups were analyzed for statistical significance using ANOVA with a Tukey-Kramer post hoc test or an unpaired t test, when appropriate, to determine the differences. All statistical analyses were performed using the JMP 9.0 software package (SAS Institute, Cary, NC).
Results
miR-200a-3p is downregulated in murine lupus CD4 + T cells
To identify new candidate miRNAs involved in the pathogenesis of SLE, we performed Illumina HiSeq to record the expression of miRNA and mRNA of CD4 + T cells isolated from the spleens of MRL/lpr mice and B6 mice. A total of 45 miRNAs were downregulated, and 69 miRNAs were upregulated in MRL/lpr mice compared with the control mice when cut-off values were defined as ,0.5 and .2, respectively. In the present study we focused on the miRNAs downregulated in MRL/lpr mice compared with B6 mice (Table I) . Among these, we selected miRNAs that were downregulated (,0.5) and were associated with significant upregulation of their target mRNAs demonstrated by RNA sequencing. During the selection process, miR-200a-3p (target mRNAs with significance: oxidized low-density lipoprotein receptor 1, Tmem56, aldehyde dehydrogenase family 1, subfamily A1 [Aldh1a1]), miR181a-5p (Clec4e), miR-101a-3p (Abcd2), and miR-466p-3p (Nrg1, Tex15) were identified. By quantitative real-time PCR, only miR-200a-3p was reproducibly downregulated in MRL/lpr mice compared with B6 mice (Fig. 1B) . Next, we assessed whether the B6 mouse is appropriate as the control of MRL/lpr and whether the genetic background affected the expression of miR-200a-3p. Age-and sex-matched MRL/MPJ (Fas +/+ ) mice that present late and mild autoimmune phenotype (23, 24) were in- cluded to control for the genetic background. As shown in Fig. 1C , the levels of miR-200a-3p were still significantly decreased in MRL/lpr mice compared with MRL/MPJ mice, and MRL/MPJ mice also presented lower levels of miR-200a-3p compared with B6 mice. As shown in Fig. 1D , the levels of miR-200a-3p were already decreased in MRL/lpr mice compared with B6 mice at younger age (8 wk old). miR-200a-3p levels increased at older age in both mice; however, the expression was still significantly lower in MRL/lpr mice. These results suggest that decreased miR-200a-3p is seen in MRL/MPJ mice independent of the Fas mutation, and the trend starts prior to the onset of disease.
ZEB2 and CtBP2 are the candidate targets of miR-200a-3p
We next investigated the target genes of miR-200a-3p that were upregulated in MRL/lpr compared with B6 mice. We retrieved the predicted and validated target genes of miR-200a-3p using TargetScan, and their mRNA expressions were evaluated by RNA sequencing data. As the candidate target genes of miR-200a-3p, oxidized lowdensity lipoprotein receptor 1, Aldh1a1, ZEB2, CtBP2, and Kr€ uppellike factor 12 were selected, because they demonstrated upregulation with statistically significant differences or have been reported to be functionally related to the regulation of the immune system. Among them, Aldh1a1, ZEB2, and CtBP2 were reproducibly upregulated ( Fig. 2 and data not shown). Because CtBP2 and ZEBs are transcription factors and form the complex coordinating the expression of various genes, we focused on CtBP2 and ZEB2. The mRNA expression of ZEB1 was rather reduced by RNA sequencing (Fig. 2) , and we further confirmed the mRNA expression by quantitative RT-PCR. Because the target sequence for miR-200a-3p was confirmed in the 39-UTR of both the ZEB1 and ZEB2 genes, and because both ZEB1 and ZEB2 recruit CtBP2 for its suppressive activity, we investigated both ZEB1 and ZEB2 in the subsequent experiments.
Gain of function of miR-200a-3p decreases ZEB1/ZEB2/CtBP2 expression and increases IL-2 production
To determine the gain effect of miR-200a-3p, miR-200a-3p mimic or control mimic was transfected into EL4 mouse T cell lines by lipofection. The transfection efficacy of miR-200a-3p was confirmed by quantitative PCR in each experiment (Fig. 3A) . As shown in Fig. 3B , the mRNA levels of ZEB1, ZEB2, and CtBP2 were significantly decreased upon overexpression of miR-200a-3p, demonstrating that miR-200a-3p negatively regulates the expressions of ZEB1, ZEB2, and CtBP2.
We also assessed whether miR-200a-3p influences IL-2 expression, because it has been reported that ZEB1 suppresses IL-2 by recruiting CtBP2 (17) . EL4 T cells transfected with miR-200a-3p mimic or control mimic were stimulated with PMA (10 ng/ml) and Iono (1 mM). IL-2 mRNA levels were measured by quantitative PCR after 6 h of PMA/Iono stimulation, and IL-2 protein levels in the supernatants were measured by ELISA after 24 h of stimulation. As shown in Fig. 3C (left) and 3D (left), IL-2 expression was significantly upregulated by the overexpression of miR200a-3p at both the mRNA and cytokine levels. IL-2 expression displayed the same change when cells were stimulated with anti-CD3/CD28 Abs (Fig. 3C , right, 3D, right), although the peak of IL-2 expression was later compared with the stimulation with PMA/Iono (peak at 6 h versus 24 h). In the following experiments, PMA/Iono stimulation was chosen considering that it evokes higher levels of IL-2 and at earlier time points. We then performed luciferase reporter assays to determine whether miR200a-3p regulated IL-2 promoter activity. We used pIL-2(-585)-Luc, which includes the murine IL-2 promoter 2585 to 234 relative to the transcription start site (25) . EL4 T cells were cotransfected with IL-2 promoter luciferase construct and miR-200a-3p mimic or control mimic and stimulated with PMA/Iono for 24 h that has been set as the peak of IL-2 according to the pre-examined time course. As shown in Fig. 3E , the overexpression of miR-200a-3p significantly increased the IL-2 promoter activity after 24 h of stimulation. These results indicate that miR-200a-3p promotes IL-2 production through the activation of the IL-2 promoter and suggest that miR-200a-3p modulates the ZEB1, ZEB2, and CtBP2 expression and activity for the transcriptional regulation of IL-2 production.
miR-200a-3p underrecruits ZEB1, ZEB2, and CtBP2 directly to the IL-2 promoter
We next investigated whether miR-200a-3p has an effect on the direct bindings of ZEB1, ZEB2, and CtBP2 to the IL-2 promoter.
It has been reported that ZEB1 binds to NRE-A 100 bp from the transcription start site of the IL-2 gene and suppresses IL-2 production (16) (Fig. 4A) . Additionally, ZEB1 and ZEB2 have been reported to recognize 59-CACCT-39 in various promoters by their zinc finger cluster, which also applies to the NRE-A sequence (26) . To determine whether ZEB1, ZEB2, and CtBP2 bind to NRE-A under the regulation of miR-200a-3p, EMSA was first performed in an EL4 cell line overexpressing miR200a-3p. Nuclear extracts isolated from the EL4 cells with 6 h stimulation of PMA/Iono were incubated with 39 biotin-labeled dsNRE-A oligonucleotide in EMSA. The protein-NRE-A mixtures were then subjected to a native PAGE. As shown in lanes 1-6 of Fig. 4B , the specific band position of protein-NRE-A probe complex was primarily examined as positive control band. The protein-NRE-A probe complex (lane 1) was abolished by 200-fold excess of unlabeled NRE-A probe (lane 2), whereas an equal amount of unlabeled mutant-NRE-A probe failed to achieve such effects (lane 3). A supershift assay was performed using the Abs against the transcription factors and showed that ZEB1 (filled arrow in Fig. 4B, lane 4) and CtBP2 with a faint band, but not ZEB2, were composed of a complex of proteins and oligonucleotide.
Furthermore, the overexpression of miR-200a-3p mimic reduced the protein-NRE-A complex compared with negative control mimic (open arrows in Fig. 4B, lanes 7 and 8) , demonstrating that miR-200a-3p reduces the binding of ZEB1 and CtBP2 on NRE-A, which results in a reduction in the suppressive activity of the ZEB1-CtBP2 complex on the IL-2 promoter. To further confirm this notion, we performed a ChIP assay. EL4 cells transfected with miR-200a-3p mimics or control mimics were stimulated for 6 h and then advanced to the crosslink step. The ChIP assay showed significantly reduced recruitment of ZEB1, ZEB2, and CtBP2 on NRE-A under conditions of overexpression of miR-200a-3p (Fig. 5A) , indicating that ZEB2 is also able to bind to NRE-A and is negatively regulated by miR-200a-3p.
The ZEB1-CtBP2 complexes fail to dissociate from the NRE-A in the IL-2 promoter after stimulation in lupus-prone mice
To clarify whether ZEB1-CtBP2 and ZEB2-CtBP2 (ZEB1/ZEB2-CtBP2) complexes on NRE-A influence the IL-2 production after stimulation in lupus-derived T cells, we performed ChIP assays using CD4 + T cells derived from the spleen of MRL/lpr mice and B6 mice. At first, IL-2 hypoproduction was confirmed anew in MRL/lpr-derived CD4 + T cells compared with B6 (Fig. 5B) . Regarding the dynamics of the ZEB1 on NRE-A, it has been reported that the binding activity reached its peak at 6 h after PMA/Iono stimulation, after which the binding abruptly declines at 9 h of stimulation in EL4 cells (16) . This is consistent with the time course of IL-2 transcription initiation after PMA/Iono stimulation, as can be seen in Fig. 3C . Therefore, the time course was set as 0, 6, and 9 h. As expected, the dynamics of the binding of ZEB1, ZEB2, and CtBP2 to NRE-A reached a peak at 6 h and significantly decreased at 9 h after PMA/Ion stimulation in B6 mice (Fig. 5C) . Alternatively, the kinetics was impaired in MRL/lpr mice, and the binding levels for ZEB1 and CtBP2 but not ZEB2 were significantly higher throughout the time course of the experiment after stimulation (Fig. 5C) .
These results indicate that the ZEB1-CtBP2 complexes in MRL/lpr mice are unresponsive to the stimulation and fail to dissociate from the NRE-A, whereas the complex dissociates from NRE-A under stimulation to produce sufficient IL-2 in the control mice (Fig. 5C , 6 h versus 9 h). The binding ability of ZEB2 was also accumulated after stimulation in MRL/lpr-derived CD4 + T cells; however, the enrichment was rather low in MRL/lpr mice compared with B6 cells (Fig. 5C ). These results demonstrated that the dysregulation of ZEB1-CtBP2 complexes binding to NRE-A upon the stimulation is crucially associated with IL-2 hypoproduction in MRL/lpr mice. Taken together with the gain-of-function findings in EL4 cells, these results suggest that miR-200a-3p regulates the ZEB1/ZEB2-CtBP2 complexes on NRE-A upon stimulation in murine T cells and influences IL-2 production (Fig. 6A) . In the lupus model, the ZEB1-CtBP2 complex is critical in suppressing IL-2 and ZEB2 may be only partially regulated by miR-200a-3p (Fig. 6B) .
Discussion
In the present study, we found that miR-200a-3p positively regulates IL-2 production in murine T cells through the recruitment of ZEB1-CtBP2 and ZEB2-CtBP2 (ZEB1/ZEB2-CtBP2) complexes to the IL-2 gene promoter. Also in humans, the serum and urinary levels of miR-200a, miR-200b, and miR-200c have been reported to be significantly decreased in active SLE patients compared with healthy subjects. Additionally, the miR-200a expression correlated inversely with proteinuria and SLEDAI (27) . This report supports our data and suggests that miR-200a may also play an important role in patients with SLE.
It has been determined that all miR-200 family members negatively regulate ZEB1 and ZEB2 and suppress EMT by binding to the 39-UTR of ZEB1 and ZEB2, whereas ZEB1 and ZEB2 bind to the promoter region of the miR-200 family members and decrease the expression of the miR-200 family in various cancer models (28) (29) (30) (31) (32) (33) (34) . miR-200 family members are divided into two groups ZEB1 was first reported as Nil-2-a to bind to NRE-A and suppress IL-2 in Jurkat T cells. ZEB1 is also associated with the differential production of IL-2 in Th1/2 EL4 cells. Although there is no previous report on the mechanism whereby ZEB2 influences IL-2 production, it has been reported that ZEB2 also binds to 59-CACCT-39 in the NRE-A sequence through its zinc finger motif (42) . Our study has revealed the impaired balance of miR-200a-3p and ZEB1/ZEB2 in murine T cells and demonstrated the functional impact of miR-200a-3p on IL-2 production.
There is some discrepancy between gain-of-function analysis in EL4 cells and mouse primary CD4 + T cells in the point that ZEB1 mRNA and the ZEB2-CtBP2 complex were not fully regulated in MRL/lpr mice with decreased level of miR-200a-3p. These results suggest the presence of other regulators in vivo and that the miR200a-3p/ZEB1/ZEB2 loop in MRL/lpr mice might also be regulated by other miRNAs or transcription factors or suppressors.
Because IL-2 production under stimulation in SLE is markedly impaired, we were intrigued by the effects of the ZEB1, ZEB2, and CtBP2 on NRE-A after stimulation. It was previously reported that c-Rel, an activator of IL-2, failed to access near the NRE-A site with anti-CD3/CD28 stimulation, whereas the activator was able to bind with PMA/Iono stimulation (43) . This fact may suggest that anti-CD3/CD28 stimulation is not sufficient for dissociating suppressive factors on the NRE-A, and therefore we selected PMA/ Iono stimulation to assess the NRE-A binding ability. As expected, ZEB1 and CtBP2, except ZEB2, were significantly accumulated on the NRE in MRL/lpr mice compared with B6 mice after stimulation (Fig. 5C ). CtBP2 was consistently upregulated in MRL/lpr mice at the mRNA and nuclear protein levels in MRL/lpr CD4 + T cells (Figs. 2, 5C ). CtBP2 is critically regulated by miR-200a-3p, which has the essential role for suppressing ability of ZEB1 and ZEB2 against IL-2.
It is still unclear which factors regulate the transcriptional activities and maturation of miR-200a-3p. As mentioned before, ZEB1 and ZEB2 are known to directly regulate the miR-200 family. Interestingly, EBV negatively regulates miR-200a and miR-200b in gastric cancer (44) . EBV is considered as a trigger for the onset of SLE; therefore, an miR-200a-3p-mediated pathway might be a candidate for the development of SLE.
It is also intriguing that the miR-200a-3p may act on Tregs. If miR-200a-3p can regulate Tregs by increasing IL-2, then targeting Tregs may be a useful therapeutic option for patients with SLE. Our study revealed the critical role of miR-200a-3p in the regulation of IL-2 through ZEB1, ZEB2, and CtBP2. An IL-2 defect in SLE is linked to a reduction in the numbers of Tregs and an increase in the numbers of autoreactive T cells. Low-dose IL-2 therapy has shown promising results in correcting reduced numbers of Tregs in SLE + T cells from MRL or B6 mice were stimulated with PMA/Iono for 6 and 9 h. The cells were promptly advanced to the crosslink step. Quantitative PCR was performed using an NRE-A primer. The ChIP results are presented as a percentage of 2% input DNA (mean 6 SEM). Data are shown from three independent experiments (A), three independent experiments with n = 3 per group (B), and n = 8 per MRL group, n = 40 per B6 group, 14-wk-old female (C). *p , 0.05, **p , 0.01, ***p , 0.001. (5) . Therefore, investigating the mechanism of IL-2 defect will clarify the central pathogenesis of SLE.
In conclusion, we have demonstrated that miR-200a-3p positively regulates IL-2 through the ZEB1/ZEB2-CtBP2 complexes binding to the NRE-A site of the IL-2 promoter in murine T cells. The ability of the ZEB1-CtBP2 complexes to dissociate from the NRE-A cite was impaired upon PMA/Iono stimulation in MRL/ lpr-derived CD4 + T cells compared with B6. miR-200a-3p mimics may therefore be useful for correcting the IL-2 defect in SLE by regulating the ZEB1/ZEB2-CtBP2 complexes. + T cells and produce IL-2. In contrast, the complexes hardly dissociate from NRE-A in primary murine lupus CD4 + T cells after stimulation and subsequently fail to produce IL-2. ZEB, ZEB1 or ZEB2.
